Korro Announces Oversubscribed $85 Million Private Placement

Korro Announces Oversubscribed $85 Million Private Placement

CAMBRIDGE, Mass., March 09, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company developing a new class of genetic medicines based on editing RNA for rare and highly prevalent diseases, today announced it has entered in…

  • Financing led by new investor Venrock Healthcare Capital Partners, with participation from new and existing investors
  • Proceeds support the achievement of value inflection poi… [+8305 chars]